Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6
- PMID: 17141510
- DOI: 10.1016/j.nbd.2006.10.007
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6
Abstract
Oxidative stress and protein aggregation are biochemical hallmarks of Parkinson's disease (PD), a frequent sporadic late-onset degenerative disorder particularly of dopaminergic neurons in the substantia nigra, resulting in impaired spontaneous movement. PARK6 is a rare autosomal-recessively inherited disorder, mimicking the clinical picture of PD with earlier onset and slower progression. Genetic data demonstrated PARK6 to be caused by mutations in the protein PINK1, which is localized to mitochondria and has a serine-threonine kinase domain. To study the effect of PINK1 mutations on oxidative stress, we used primary fibroblasts and immortalized lymphoblasts from three patients homozygous for G309D-PINK1. Oxidative stress was evident from increases in lipid peroxidation and in antioxidant defenses by mitochondrial superoxide dismutase and glutathione. Elevated levels of glutathione reductase and glutathione-S-transferase were also observed. As a putative cause of oxidation, a mild decrease in complex I activity and a trend to superoxide elevation were detectable. These data indicate that PINK1 function is critical to prevent oxidative damage and that peripheral cells may be useful for studies of progression and therapy of PARK6.
Similar articles
-
Parkinson patient fibroblasts show increased alpha-synuclein expression.Exp Neurol. 2008 Aug;212(2):307-13. doi: 10.1016/j.expneurol.2008.04.004. Epub 2008 Apr 16. Exp Neurol. 2008. PMID: 18511044
-
Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population.Parkinsonism Relat Disord. 2008;14(1):52-7. doi: 10.1016/j.parkreldis.2007.06.009. Epub 2007 Nov 26. Parkinsonism Relat Disord. 2008. PMID: 18032086
-
Sleep quality in a family with hereditary parkinsonism (PARK6).Sleep Med. 2008 Aug;9(6):684-8. doi: 10.1016/j.sleep.2007.07.004. Epub 2007 Sep 4. Sleep Med. 2008. PMID: 17766179
-
Genetic mutations and functions of PINK1.Trends Pharmacol Sci. 2011 Oct;32(10):573-80. doi: 10.1016/j.tips.2011.06.001. Epub 2011 Jul 23. Trends Pharmacol Sci. 2011. PMID: 21784538 Review.
-
Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.Apoptosis. 2010 Nov;15(11):1336-53. doi: 10.1007/s10495-010-0465-0. Apoptosis. 2010. PMID: 20131004 Review.
Cited by
-
Mitochondrial dysfunction and oxidative stress in Parkinson's disease.Prog Neurobiol. 2013 Jul-Aug;106-107:17-32. doi: 10.1016/j.pneurobio.2013.04.004. Epub 2013 Apr 30. Prog Neurobiol. 2013. PMID: 23643800 Free PMC article. Review.
-
Silent information regulator 2 (Sir2) and Forkhead box O (FOXO) complement mitochondrial dysfunction and dopaminergic neuron loss in Drosophila PTEN-induced kinase 1 (PINK1) null mutant.J Biol Chem. 2012 Apr 13;287(16):12750-8. doi: 10.1074/jbc.M111.337907. Epub 2012 Feb 29. J Biol Chem. 2012. PMID: 22378780 Free PMC article.
-
Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts.Ann Neurol. 2008 Nov;64(5):555-65. doi: 10.1002/ana.21492. Ann Neurol. 2008. PMID: 19067348 Free PMC article.
-
Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells.PLoS One. 2009;4(3):e4756. doi: 10.1371/journal.pone.0004756. Epub 2009 Mar 9. PLoS One. 2009. PMID: 19270741 Free PMC article.
-
Tickled PINK1: mitochondrial homeostasis and autophagy in recessive Parkinsonism.Biochim Biophys Acta. 2010 Jan;1802(1):20-8. doi: 10.1016/j.bbadis.2009.06.012. Epub 2009 Jul 9. Biochim Biophys Acta. 2010. PMID: 19595762 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials